SlideShare uma empresa Scribd logo
1 de 37
Speaker’s name: Dr Ramachandra Barik,
                Assistant professor
                Department of cardiology
                Nizam’s Institute of Medical science.
                Hyderabad
                INDIA.


 I do not have any potential conflict of interest
Device Closure Of Ventricular Septal Defect after 3 Weeks
                of Coronary Angioplasty.
HAPPY NEW
YEAR 2012




            Dr Barik.
CLINICAL HISTORY


    60 YR/M, SMOKER, NON-DM, NON-HTN
    AWMI +STK+ ON 1.8.2011 WITHIN WINDOW
     PERIOD OF 4 HRS AT A DISTRICT HOSPITAL
    SOB AT REST
    ON DAY 3-(3.8.2011)- PSM
    ECG –AWMI
    2D ECHO- VSD ; MODERATE LV DYSFUNCTION
    REFERRED TO OUR HOSPITAL FOR FURTHER
     MANAGEMENT
ON EXAMINATION-

    KILLIP II & ANGINA AT REST
    BP: 100/70 MMHG, PULSE :109/MIN, RR: 22/MIN, AFEBRILE
    JVP: NORMAL, LV – S3+, PSM IV/VI
    ROOM AIR ARTERIAL SAT. 95%
    OTHER SYSTEMS : B/L BASILLIAR CREPTS
12 LEAD ECG
12 LEAD ECG: TACHYCARDIA; Q – V1-V4
2D/3D-ECHO -04.08.2011


     RWMA + ( LAD TERRITORY HYPOKINETIC),
     ANTERO-APICAL VSD OF SIZE 10 mm,
     LVEF-35%,
     DIASTOLIC DYSFUNCTION +,
     NO PE, NO CLOT.
2D ECHO –APICAL 4C




VSD -1.8CM
FROM APEX
TOWARDS BASE
COLOUR DOPPLER – 4C :VSD
COLOUR COMPARISION
COLOUR COMPARISION
CAG + CATH (4.8.2011):
  Hb-14gm%, with BMI- 22.03kg/m2; O2 CONS-200/MT


     SVC - 50 %
                                   RA – 2 MM HG
     IVC - 76%
                                   RV – 20/0-4
    MVO2 - 56.5%
                                   PA – 20/12 ,15
     RA - 62%                      PCWP - 17
    RV - 83%
                                   LV -100/0-8
     PA - 80%
                                   FA – 100/70
     FA - 92%

                         Qp/Qs - 1.86:1
LAD -LESION
RCA NORMAL
LV ANGIO-SINGLE MUSCULAR VSD
PLAN:Follow Guidelines?

   PTCA TO LAD ?
   PTCA+VSD CLOSURE ?
   STAGED PROCEDURE ?
   SURGERY ?
PTCA TO LAD
ENDEAVOR
RESOLUTE 3X15
MM
S
SH ARE YOUR IDEA
                 D
PL EASE-IDEAL VS
CLOSING TIME
DEVICE OPTION




Amplatzer VSD Occluder-
FAD APPROVED                        Cardi-O-Fix from Starway
                                    Medical Technology,Inc.
DELIVERY SYSTEM
Cardi-O-Fix 10mm device through 9 Fr sheath
ARTERIO-VENOUS LOOP



TERUMO- J
-TIPPED- 0.35”
X 260 CM
SNARING IN PA

AMPLATZER
GOOSE-NECK
10MM
SNARE;MICROVEN
A CORPO.
DELIVERY SHEATH ACROSS VSD


12 Fr x1800 CURVE
STARWAY MEDICAL
TECH.
VSD OCCLUDER


CARDIO-O-FIX
14 M.
[STARWAY
MEDICAL].
AFTER RELEASE
ECHO AFTER 3MONTHS
REVIEW   OF   LITERATURE
1. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk
factors, angiographic patterns, and outcomes in patients with ventricular septal defect
complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase
and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32.
2. Labrousse L, Choukroun E, Chevalier JM, Madonna F, Robertie F, Merlico F, et al.
Surgery for post infarction ventricular septal defect (VSD): risk factors for hospital death
and long term results. Eur J Cardiothorac Surg 2002;21:725-31.
3. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects.
State of the art. J Cardiovasc Med 2007;8:39-45.
4. Ahmed J, Ruygrok PN, Wilson NJ, Webster MW, Greaves S, Gerber I. Percutaneous
closure of post-myocardial infarction ventricular septal defects: a single centre experience.
Heart Lung Circ 2008;17:119-23.
5. Martinez MW, Mookadam F, Sun Y, Hagler DJ. Transcatheter closure of ischemic and
post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv 2007; 69:403-7.
6. Goldstein JA, Casserly IP, Balzer DT, Lee R, Lasala JM. Transcatheter closure of
recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer
postinfarction VSD device: a case series. Catheter Cardiovasc Interv 2003;59:238-43.
7. Caputo M, Wilde P, Angelini GD. Management of postinfarction ventricular septal defect.
Br J Hosp Med 1995;54:562-6.
8. Hachida M, Nakano H, Hirai M, Shi CY. Percutaneous transaortic closure of
postinfarctional ventricular septal rupture. Ann Thorac Surg 1991;51:655-7.
9. Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, et al. Immediate
primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009;
30:81-8.
10. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial
infarction ventricular septal defect with the Amplatzer septal occluder. Heart 1998; 80:522-4.
CASE REPORT

A 61-year-old male, hypertensive and diabetic for the past 20 years, was brought to

coronary care unit in CCF. He had sustained an anterior wall MI the previous day and was

thrombolyzed with streptokinase. On admission, pulse rate was 110/min and BP was

130/90 mm Hg. Auscultation revealed ……………….. Ajit S. Mullasari,*

MD,et.al.MMM,Chenai.

Catheterization and Cardiovascular Interventions 54:484–487 (2001)
Between Sep.2003 and Feb. 2008, 29 consecutive patients underwent primary
transcatheter VSD closure. Clinical, procedural, and outcome data were collected.
Patients were divided into those with and those without cardiogenic shock at
presentation for risk stratification.
 The median follow-up time of surviving patients was 730 days. The median time
between VSD occurrence and closure was 1 day [interquartile range (IQR) 1–3]
 the initial procedural success rate was 86%.
The shunt (Qp:Qs) could be reduced from 3.3 (IQR 2.3–3.8) to 1.4 (IQR 1.2–1.7; P , 0.001)
Procedure-related complications such as major residual shunting, LV rupture, and device
embolization occurred in 41%. The overall 30-day survival rate was 35%.
 Mortality was higher for cardiogenic shock in comparison to non-shock patients (88 vs.
38%, P , 0.001).
Holger Thiele1*,et.al
TAKE HOME MESSAGE


   USE OF CARDIO-O-FIX DEVICE
   INITIAL PTCAGAP OF 3 WEEKSVSD CLOSURE
   AVOIDANCE OF GA,TEE,BALLOON SIZING.
   NOT USED ANY STIFF GUIDE WIRE


 MAKE THE PROCEDURE AS SIMPLE AS POSSIBLE WITH LEAST
  EXPENDITURE
THANK U GIVING ME THIS OPPORTUNITY
               TO
           TO SHARE.

Mais conteúdo relacionado

Mais procurados

Valvula mitral conroversias
Valvula mitral conroversiasValvula mitral conroversias
Valvula mitral conroversias
lfrivas
 
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Pedro Martinez-Clark, M.D.
 
Esc patient selection for Mitraclip
Esc patient selection for MitraclipEsc patient selection for Mitraclip
Esc patient selection for Mitraclip
drmaisano
 
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013 Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Fina Mauri
 

Mais procurados (20)

Cafri C
Cafri CCafri C
Cafri C
 
Hybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissectionHybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissection
 
Valvula mitral conroversias
Valvula mitral conroversiasValvula mitral conroversias
Valvula mitral conroversias
 
Patient prosthesis mismatch
Patient prosthesis mismatchPatient prosthesis mismatch
Patient prosthesis mismatch
 
Options for tough situation
Options  for tough situationOptions  for tough situation
Options for tough situation
 
Combined carotid and coronary disease the strategy should be
Combined carotid and coronary disease the strategy should beCombined carotid and coronary disease the strategy should be
Combined carotid and coronary disease the strategy should be
 
Embolic protection devices yadav- cleveland clinic
Embolic protection devices  yadav- cleveland clinicEmbolic protection devices  yadav- cleveland clinic
Embolic protection devices yadav- cleveland clinic
 
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
Transcaval Retrograde Transcatheter Aortic Valve Replacement for Patients Wit...
 
Embolic protection devices
Embolic protection devicesEmbolic protection devices
Embolic protection devices
 
Myocardial protection in redo surgery with patent left internal mammary artery
Myocardial protection in redo surgery with patent left internal mammary arteryMyocardial protection in redo surgery with patent left internal mammary artery
Myocardial protection in redo surgery with patent left internal mammary artery
 
Management of aaa clinical practice guidelines of the esvs
Management of aaa clinical practice guidelines of the esvsManagement of aaa clinical practice guidelines of the esvs
Management of aaa clinical practice guidelines of the esvs
 
Urgent management of tia
Urgent management of tiaUrgent management of tia
Urgent management of tia
 
Eversion or standard carotid endarterectomy local or general anesthesia does ...
Eversion or standard carotid endarterectomy local or general anesthesia does ...Eversion or standard carotid endarterectomy local or general anesthesia does ...
Eversion or standard carotid endarterectomy local or general anesthesia does ...
 
Carotid body tumors review of 56 cases
Carotid body tumors  review of 56 casesCarotid body tumors  review of 56 cases
Carotid body tumors review of 56 cases
 
Esc patient selection for Mitraclip
Esc patient selection for MitraclipEsc patient selection for Mitraclip
Esc patient selection for Mitraclip
 
Dr.yadavemboliz2
Dr.yadavemboliz2Dr.yadavemboliz2
Dr.yadavemboliz2
 
Dr.yadavemboliz2
Dr.yadavemboliz2Dr.yadavemboliz2
Dr.yadavemboliz2
 
Guidelines in the management of carotid stenosis
Guidelines in the management of carotid stenosisGuidelines in the management of carotid stenosis
Guidelines in the management of carotid stenosis
 
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013 Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
 
Transcatheter mitral valve repair
Transcatheter mitral valve repairTranscatheter mitral valve repair
Transcatheter mitral valve repair
 

Semelhante a conference presentation of your reseach

[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
Thọ Văn
 

Semelhante a conference presentation of your reseach (20)

Post mi vsd ppt
Post mi vsd pptPost mi vsd ppt
Post mi vsd ppt
 
Valvula mitral conroversias
Valvula mitral conroversiasValvula mitral conroversias
Valvula mitral conroversias
 
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting developmentKedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
 
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivasDr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
Dr. Alexander Parkhomenko. Utilidad de las nuevas técnicas de imagen invasivas
 
Vedantham_2008-12-12.ppt
Vedantham_2008-12-12.pptVedantham_2008-12-12.ppt
Vedantham_2008-12-12.ppt
 
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stentingRuzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
 
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
 
Optimal Candidates for Bioresorbable Vascular Scaffolds
Optimal Candidates for Bioresorbable Vascular ScaffoldsOptimal Candidates for Bioresorbable Vascular Scaffolds
Optimal Candidates for Bioresorbable Vascular Scaffolds
 
Endovascular and surgical treatment of pulmonary embolism 26.11.17
Endovascular and surgical treatment of pulmonary embolism 26.11.17Endovascular and surgical treatment of pulmonary embolism 26.11.17
Endovascular and surgical treatment of pulmonary embolism 26.11.17
 
Cardiac petct ahmed tawakol
Cardiac petct ahmed tawakolCardiac petct ahmed tawakol
Cardiac petct ahmed tawakol
 
Ec ic bypass
Ec ic bypassEc ic bypass
Ec ic bypass
 
Flex Registry
Flex RegistryFlex Registry
Flex Registry
 
Laser 1470nm , low leed,radial fiber and non
Laser 1470nm , low leed,radial fiber and  nonLaser 1470nm , low leed,radial fiber and  non
Laser 1470nm , low leed,radial fiber and non
 
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...
 
Cardiac dyssynchrony ppt by dr awadhesh
Cardiac dyssynchrony ppt   by dr awadheshCardiac dyssynchrony ppt   by dr awadhesh
Cardiac dyssynchrony ppt by dr awadhesh
 
History and Future of Transcatheter Mitral Valve Interventions
History and Future of Transcatheter Mitral Valve InterventionsHistory and Future of Transcatheter Mitral Valve Interventions
History and Future of Transcatheter Mitral Valve Interventions
 
1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal1362573078 dr. rajdeep agrawal
1362573078 dr. rajdeep agrawal
 
How should recently symptomatic patients be treated urgent cea or cas
How should recently symptomatic patients be treated urgent cea or casHow should recently symptomatic patients be treated urgent cea or cas
How should recently symptomatic patients be treated urgent cea or cas
 
[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
[123doc] - bai-giang-sieu-am-tim-3d-trong-danh-gia-va-can-thiep-cac-benh-ly-v...
 
Coronary ct angiography in the er
Coronary ct angiography in the erCoronary ct angiography in the er
Coronary ct angiography in the er
 

Mais de Ramachandra Barik

Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
Ramachandra Barik
 

Mais de Ramachandra Barik (20)

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
 

Último

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Último (20)

Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 

conference presentation of your reseach

  • 1. Speaker’s name: Dr Ramachandra Barik, Assistant professor Department of cardiology Nizam’s Institute of Medical science. Hyderabad INDIA.  I do not have any potential conflict of interest
  • 2. Device Closure Of Ventricular Septal Defect after 3 Weeks of Coronary Angioplasty.
  • 4. CLINICAL HISTORY  60 YR/M, SMOKER, NON-DM, NON-HTN  AWMI +STK+ ON 1.8.2011 WITHIN WINDOW PERIOD OF 4 HRS AT A DISTRICT HOSPITAL  SOB AT REST  ON DAY 3-(3.8.2011)- PSM  ECG –AWMI  2D ECHO- VSD ; MODERATE LV DYSFUNCTION  REFERRED TO OUR HOSPITAL FOR FURTHER MANAGEMENT
  • 5. ON EXAMINATION-  KILLIP II & ANGINA AT REST  BP: 100/70 MMHG, PULSE :109/MIN, RR: 22/MIN, AFEBRILE  JVP: NORMAL, LV – S3+, PSM IV/VI  ROOM AIR ARTERIAL SAT. 95%  OTHER SYSTEMS : B/L BASILLIAR CREPTS
  • 6. 12 LEAD ECG 12 LEAD ECG: TACHYCARDIA; Q – V1-V4
  • 7. 2D/3D-ECHO -04.08.2011 RWMA + ( LAD TERRITORY HYPOKINETIC), ANTERO-APICAL VSD OF SIZE 10 mm, LVEF-35%, DIASTOLIC DYSFUNCTION +, NO PE, NO CLOT.
  • 8. 2D ECHO –APICAL 4C VSD -1.8CM FROM APEX TOWARDS BASE
  • 12. CAG + CATH (4.8.2011): Hb-14gm%, with BMI- 22.03kg/m2; O2 CONS-200/MT SVC - 50 % RA – 2 MM HG IVC - 76% RV – 20/0-4 MVO2 - 56.5% PA – 20/12 ,15 RA - 62% PCWP - 17 RV - 83% LV -100/0-8 PA - 80% FA – 100/70 FA - 92%  Qp/Qs - 1.86:1
  • 16. PLAN:Follow Guidelines?  PTCA TO LAD ?  PTCA+VSD CLOSURE ?  STAGED PROCEDURE ?  SURGERY ?
  • 18. S SH ARE YOUR IDEA D PL EASE-IDEAL VS CLOSING TIME
  • 19. DEVICE OPTION Amplatzer VSD Occluder- FAD APPROVED Cardi-O-Fix from Starway Medical Technology,Inc.
  • 21.
  • 22. Cardi-O-Fix 10mm device through 9 Fr sheath
  • 23.
  • 26. DELIVERY SHEATH ACROSS VSD 12 Fr x1800 CURVE STARWAY MEDICAL TECH.
  • 30. REVIEW OF LITERATURE
  • 31. 1. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32. 2. Labrousse L, Choukroun E, Chevalier JM, Madonna F, Robertie F, Merlico F, et al. Surgery for post infarction ventricular septal defect (VSD): risk factors for hospital death and long term results. Eur J Cardiothorac Surg 2002;21:725-31. 3. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med 2007;8:39-45. 4. Ahmed J, Ruygrok PN, Wilson NJ, Webster MW, Greaves S, Gerber I. Percutaneous closure of post-myocardial infarction ventricular septal defects: a single centre experience. Heart Lung Circ 2008;17:119-23. 5. Martinez MW, Mookadam F, Sun Y, Hagler DJ. Transcatheter closure of ischemic and post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv 2007; 69:403-7.
  • 32. 6. Goldstein JA, Casserly IP, Balzer DT, Lee R, Lasala JM. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series. Catheter Cardiovasc Interv 2003;59:238-43. 7. Caputo M, Wilde P, Angelini GD. Management of postinfarction ventricular septal defect. Br J Hosp Med 1995;54:562-6. 8. Hachida M, Nakano H, Hirai M, Shi CY. Percutaneous transaortic closure of postinfarctional ventricular septal rupture. Ann Thorac Surg 1991;51:655-7. 9. Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009; 30:81-8. 10. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder. Heart 1998; 80:522-4.
  • 33. CASE REPORT A 61-year-old male, hypertensive and diabetic for the past 20 years, was brought to coronary care unit in CCF. He had sustained an anterior wall MI the previous day and was thrombolyzed with streptokinase. On admission, pulse rate was 110/min and BP was 130/90 mm Hg. Auscultation revealed ……………….. Ajit S. Mullasari,* MD,et.al.MMM,Chenai. Catheterization and Cardiovascular Interventions 54:484–487 (2001)
  • 34. Between Sep.2003 and Feb. 2008, 29 consecutive patients underwent primary transcatheter VSD closure. Clinical, procedural, and outcome data were collected. Patients were divided into those with and those without cardiogenic shock at presentation for risk stratification. The median follow-up time of surviving patients was 730 days. The median time between VSD occurrence and closure was 1 day [interquartile range (IQR) 1–3] the initial procedural success rate was 86%. The shunt (Qp:Qs) could be reduced from 3.3 (IQR 2.3–3.8) to 1.4 (IQR 1.2–1.7; P , 0.001) Procedure-related complications such as major residual shunting, LV rupture, and device embolization occurred in 41%. The overall 30-day survival rate was 35%. Mortality was higher for cardiogenic shock in comparison to non-shock patients (88 vs. 38%, P , 0.001). Holger Thiele1*,et.al
  • 35.
  • 36. TAKE HOME MESSAGE  USE OF CARDIO-O-FIX DEVICE  INITIAL PTCAGAP OF 3 WEEKSVSD CLOSURE  AVOIDANCE OF GA,TEE,BALLOON SIZING.  NOT USED ANY STIFF GUIDE WIRE  MAKE THE PROCEDURE AS SIMPLE AS POSSIBLE WITH LEAST EXPENDITURE
  • 37. THANK U GIVING ME THIS OPPORTUNITY TO TO SHARE.